Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Lena Biosciences logo — 3D Cell Culture & Perfused-Organ-Panel MPS Technology

Lena Biosciences

3D Cell Culture & Perfused-Organ-Panel MPS Technology

Founded 2008 United States Atlanta, United States 4 employees Grant Total: $2.61M Biotechnology, Life Sciences +1

General Information

Company Name Lena Biosciences
Founded Year 2008
Location United States Atlanta, United States +1
Employees 4
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Grant
Social

Get notified when Lena Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Lena Biosciences

Lena Biosciences is a biotechnology company founded in 2008, with headquarters in the United States. The company specializes in simplifying 3D cell culture and addressing common issues encountered by scientists in the lab. Lena Biosciences offers advanced Perfused-Organ-Panel (MPS) technology and 3D cell culture products and services catering to biomedical research and in vitro drug testing. Their patented technologies are transforming cancer research and personalized drug testing by optimizing conditions for cell growth and providing accurate in vitro models. The company's mission is to streamline organ-on-a-chip technologies for researchers of all skill levels, with the aim to expedite scientific discovery. One of Lena Biosciences' notable products is PerfusionPal, a high-throughput organ-on-a-chip insert system designed to enhance drug metabolism by up to 10 times. Notably, it doesn't require specialized training and ensures reliable performance, making it suitable for addressing complex questions in research. Another product, SeedEZ, is a universal and user-friendly 3D cell culture scaffold that facilitates the simulation of living tissues, compound testing, and functionality assessment. With GradientEZ, users can easily create controlled gradients, particularly beneficial for enhancing cancer and autoimmune models for testing therapeutic strategies. Lena Biosciences recently secured a $252.12K grant investment in August 2020, with the National Institute of Environmental Health Sciences being the investor. With its innovative technologies and focus on simplifying and enhancing in vitro research, Lena Biosciences is poised for significant impact in the biotechnology and pharmaceutical industries.

Taxonomy: Organ-on-a-chip, 3D Cell Culture, Drug Testing, Precision Therapies, Biomedical Research, Cancer Research, Cell Culture Technology, Perfusion Systems, High-throughput Screening, Drug Metabolism, ADME Tox Screening, Monoclonal Antibodies, iPSC, Toxicity Testing

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 01 Aug 2020
Grant •••••• 1
Investor
01 Jul 2019
Non Equity Assistance •••••• 1
Investor
17 Apr 2019
Grant •••••• 1
Investor
01 Jul 2018
Pre Seed Round •••••• 2 •••• •••• 11 Oct 2016

View All 9 Funding Rounds

Lena Biosciences Alternatives & Competitors

Lena Biosciences vs
AlveoliX
AlveoliX Switzerland

In-vitro models inspired by nature Ι Organs-on-Chip

Grant
11 employees
Biotechnology, Life Sciences
Lena Biosciences vs
Axol Bioscience Ltd.
Axol Bioscience Ltd. United Kingdom

Better Human Disease Models

Series Unknown
49 employees
Biopharma, Biotechnology
Lena Biosciences vs
Emulate, Inc.
Emulate, Inc. United States

Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biol...

Series F
71 employees
Biotechnology, Health Care

FAQ About Lena Biosciences

3D Cell Culture & Perfused-Organ-Panel MPS Technology
Lena Biosciences was founded in 2008.
Lena Biosciences is headquartered in Atlanta, United States.
Lena Biosciences operates in the following industries: Biotechnology, Life Sciences, Pharmaceutical.
Lena Biosciences has approximately 4 employees.
Lena Biosciences has completed 9 funding rounds, raising a total of $2.61M. The latest funding stage is Grant.
Top alternatives and competitors to Lena Biosciences include AlveoliX , Axol Bioscience Ltd., Emulate, Inc., Qureator , CN Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lena Biosciences and AlveoliX are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Lena Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy